Search results for "Coronaviru"

showing 10 items of 1289 documents

Putative impact of the COVID-19 pandemic on anxiety, depression, insomnia and stress

2020

medicine.medical_specialtyCoronavirus disease 2019 (COVID-19)business.industryinsomniaAnxiety depressionInsomnia and stressCOVID-19anxietystressPsychiatry and Mental healthdepressionPandemicStress (linguistics)Insomniamedicinemedicine.symptomLetters to the EditorbusinessPsychiatryCOVID-19 anxiety depression insomnia stressThe European Journal of Psychiatry
researchProduct

Children and Coronavirus Infection (Covid-19): What to Tell Children to Avoid Post-traumatic Stress Disorder (PTSD)

2020

Post-traumatic Stress Disorder (PTSD) is a condition that can develop in subjects who have been or have witnessed a traumatic, catastrophic or violent event, or who have become aware of a traumatic experience that happened to a loved one. Acute Stress Disorder (ASD) usually begins immediately after the traumatic event and lasts from three days to a month, while Post-traumatic Stress Disorder (PTSD) may be the continuation of an acute stress disorder and it may happen that it does not develop until 6 months after the event itself. Generally most people overcome the shock that a blatant event can cause without the need for additional support. In a percentage of cases, the victim's suffering c…

medicine.medical_specialtyCoronavirus disease 2019 (COVID-19)business.industrymedicine.diseasemedicine.disease_causeSettore MED/39 - Neuropsichiatria InfantilePost-traumatic Stress DisordermedicineCovid-19PsychiatrybusinessChildrenPost-traumatic stress disorder (PTSD)CoronavirusThe Open Pediatric Medicine Journal
researchProduct

Recent Randomized Trials of Antithrombotic Therapy for Patients With COVID-19

2021

Endothelial injury and microvascular/macrovascular thrombosis are common pathophysiological features of coronavirus disease-2019 (COVID-19). However, the optimal thromboprophylactic regimens remain unknown across the spectrum of illness severity of COVID-19. A variety of antithrombotic agents, doses, and durations of therapy are being assessed in ongoing randomized controlled trials (RCTs) that focus on outpatients, hospitalized patients in medical wards, and patients critically ill with COVID-19. This paper provides a perspective of the ongoing or completed RCTs related to antithrombotic strategies used in COVID-19, the opportunities and challenges for the clinical trial enterprise, and ar…

medicine.medical_specialtyCoronavirus disease 2019 (COVID-19)business.industrymedicine.drug_classAnticoagulantState of the art review030204 cardiovascular system & hematologymedicine.diseaseThrombosislaw.inventionClinical trial03 medical and health sciences0302 clinical medicinePharmacotherapyRandomized controlled triallawAntithromboticMedicine030212 general & internal medicineCardiology and Cardiovascular MedicinebusinessIntensive care medicineJournal of the American College of Cardiology
researchProduct

Dejar de fumar en el trastorno mental grave: desafíos y oportunidades en tiempos de la COVID-1.

2020

medicine.medical_specialtyCoronavirus disease 2019 (COVID-19)business.industrymedicine.medical_treatmentMental DisordersMEDLINEMedicine (miscellaneous)COVID-19Tobacco Use DisorderMental illnessmedicine.diseasePsychiatry and Mental healthmedicineSmoking cessationHumansSmoking CessationPsychiatrybusinessPandemics
researchProduct

PRACTICAL RECOMMENDATIONS FOR THE MANAGEMENT OF PATIENTS WITH ITP DURING THE COVID-19 PANDEMIC

2021

The current COVID-19 pandemic requires revisiting our current approach to major blood disorders, including ITP (Immune Thrombocytopenia), stirring  up the production of several disease-specific practical guidelines. This report describes an updated version of consensus-based practical guidelines on the management of ITP, adapted to the Italian health system and social context.  It highlights the role of the hematologist in offering guidance for choosing differentiated approaches in relation to specific circumstances and is intended to provide them with a useful tool for sharing the decision-making process with their patients.
 Probably, the greatest risk to avoid for a patient with sus…

medicine.medical_specialtyCoronavirus disease 2019 (COVID-19)business.industrymedicine.medical_treatmentSplenectomySocial environmentHematology030204 cardiovascular system & hematologyImmune thrombocytopenia03 medical and health sciencesTherapeutic approach0302 clinical medicineInfectious DiseasesBlood Disorderhemic and lymphatic diseasesPandemicmedicine030212 general & internal medicineHematologistIntensive care medicinebusinessMediterranean Journal of Hematology and Infectious Diseases
researchProduct

The Role of Tele Dentistry During the Current Corona Virus Disease 2019 (COVID-19) And in The Possible Future Pandemic

2020

Severe acute respiratory syndrome (SARS) coronavirus (SARSCoV) is a virus that caused the first major pandemic of the third millennium...

medicine.medical_specialtyCoronavirus disease 2019 (COVID-19)business.industryvirusesfungimacromolecular substancesGeneral MedicineVirus diseasesmedicine.disease_causemedicine.diseaseVirusbody regionsPneumoniaLung diseasePandemicmedicineskin and connective tissue diseasesIntensive care medicinebusinessCoronavirusBiomedical Journal of Scientific & Technical Research
researchProduct

Worsening of pre-existing psychiatric conditions during the COVID-19 pandemic

2020

This study anonymously examined 2,734 psychiatric patients worldwide for worsening of their pre-existing psychiatric condition during the COVID-19 pandemic. Valid responses mainly from 12 featured countries indicated self-reported worsening of psychiatric conditions in 2/3rd of the patients assessed that was validated through their significantly higher scores on scales for general psychological disturbance, post-traumatic stress disorder, and depression. Female gender, feeling no control of the situation and reporting dissatisfaction with the response of the state during the COVID-19 pandemic, and reduced interaction with family and friends increased the worsening of pre-existing psychiatri…

medicine.medical_specialtyCoronavirus disease 2019 (COVID-19)media_common.quotation_subjectDeclarationPsychological interventionCommissionPsychological disturbancePsyArXiv|Social and Behavioral Sciences|Clinical PsychologyPsyArXiv|Social and Behavioral Sciences|Health Psychology|Mental HealthPsyArXiv|Social and Behavioral Sciences|Health PsychologyOptimismbepress|Social and Behavioral Sciences|Psychology|Clinical PsychologyPandemicmedicinebepress|Medicine and Health Sciences|Medical Specialties|PsychiatryPsychiatryDepression (differential diagnoses)media_commonbusiness.industryTraumatic stressMental healthPsyArXiv|Social and Behavioral SciencesFeelingbepress|Social and Behavioral Sciences|Psychology|Health PsychologyPsyArXiv|Psychiatrybepress|Social and Behavioral SciencesPsychologybusiness
researchProduct

Mental Health Impact of COVID-19: A global study of risk and resilience factors

2020

AbstractThis study anonymously screened 13,332 individuals worldwide for psychological symptoms related to Corona virus disease 2019 (COVID-19) pandemic from March 29th to April 14th, 2020. A total of n=12,817 responses were considered valid with responses from 12 featured countries and five WHO regions. Female gender, pre-existing psychiatric condition, and prior exposure to trauma were identified as notable risk factors, whereas optimism, ability to share concerns with family and friends like usual, positive prediction about COVID-19, and daily exercise predicted fewer psychological symptoms. These results could aid in dynamic optimization of mental health services during and following CO…

medicine.medical_specialtyCoronavirus disease 2019 (COVID-19)media_common.quotation_subjectVirus diseasesMental healthPsyArXiv|Social and Behavioral Sciences|Health Psychology|Mental HealthPsyArXiv|Social and Behavioral SciencesPsyArXiv|Social and Behavioral Sciences|Health PsychologyOptimismbepress|Social and Behavioral Sciences|Psychology|Health PsychologyRisk and resiliencePandemicbepress|Social and Behavioral SciencesmedicinePsychologyPsychiatrymedia_common
researchProduct

Mortality after in-hospital cardiac arrest in patients with COVID-19: A systematic review and meta-analysis.

2021

Abstract Aim To estimate the mortality rate, the rate of return of spontaneous circulation (ROSC) and survival with favorable neurological outcome in patients with COVID-19 after in-hospital cardiac arrest (IHCA) and attempted cardiopulmonary resuscitation (CPR). Methods PubMed, EMBASE, Web of Science, bioRxiv and medRxiv were surveyed up to 8th February 2021 for studies reporting data on mortality of patients with COVID-19 after IHCA. The primary outcome sought was mortality (in-hospital or at 30 days) after IHCA with attempted CPR. Additional outcomes were the overall rate of IHCA, the rate of non-shockable presenting rhythms, the rate of ROSC and the rate of survival with favorable neuro…

medicine.medical_specialtyCoronavirus disease 2019 (COVID-19)medicine.medical_treatment030204 cardiovascular system & hematologyEmergency Nursing03 medical and health sciences0302 clinical medicinePrimary outcomeInternal medicineHospital dischargeMedicineHumansIn patientcprCardiopulmonary resuscitationMortalitybusiness.industrySARS-CoV-2Neurological statusMortality rateCOVID-19030208 emergency & critical care medicineCardiac arrestCardiopulmonary ResuscitationHospitalsHeart ArrestEditorialMeta-analysisEmergency MedicineCardiology and Cardiovascular MedicinebusinessResuscitation
researchProduct

Stroke Care Within the COVID-19 Pandemic—Increasing Awareness of Transient and Mild Stroke Symptoms Needed

2020

Background: The COVID-19 pandemic might affect health care resources and alter patient admission to hospital in case of stroke or transient ischemic attack (TIA). We aim to determine whether the COVID-19 pandemic is affecting utilization of recanalization procedures and numbers of patients with stroke and TIA admitted to a primary care stroke center.Methods: In this retrospective observational study, we compared patients admitted from January 2019 until February 2020 with patients admitted during the COVID-19 pandemic (March/April 2020) in Germany. We included patients with stroke (hemorrhagic or ischemic) or TIA as classified by International Statistical Classification of Diseases and Rela…

medicine.medical_specialtyCoronavirus disease 2019 (COVID-19)medicine.medical_treatmentMild strokecerebral ischemialcsh:RC346-42903 medical and health sciencesmechanical thrombectomy0302 clinical medicineInternal medicinePandemicmedicineInternational Statistical Classification of Diseases and Related Health Problemscerebral infarct030212 general & internal medicinecardiovascular diseasesStrokelcsh:Neurology. Diseases of the nervous systemOriginal Researchbusiness.industryCOVID-19Retrospective cohort studyThrombolysismedicine.diseaseMechanical thrombectomyNeurologytransient ischemic attackNeurology (clinical)business030217 neurology & neurosurgeryFrontiers in Neurology
researchProduct